Synthesis and anticancer activities of 5,6,7-trimethylbaicalein derivatives

26Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to develop potential anticancer agents based on a naturally occurring baicalein, a flavonoid from Scatellariae radix. Cinnamic acid derivatives were converted to corresponding chlorides and then condensed with 3,4,5-trimethoxyphenol in the presence of BF3·Et 2O to give chalcones. Intramolecular cyclization of these intermediates by the actions of DMSO/I2 afforded the desired trimethylbaicalein derivatives. Cell viability after treatment with the tested compound for 2 d was determined by a colorimetric MTT assay. The results indicated that most of the derivatives showed improved inhibition of proliferation of Hep G2 cells. Compound 9 was the most potent, in which the cell viability was reduced to <2% at the 25 μM level. In the case of Hep 3B cells, 8a, 8b and 8f showed moderate inhibition of their proliferation and 25 μM was required to reduce the viability to ca. 30%. On the other hand, prostate DU145 cells were more resistant. Most of the derivatives caused a 60% inhibition of DU145 cells only at a concentration of 100 μM or above. © 2004 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Liao, H. L., & Hu, M. K. (2004). Synthesis and anticancer activities of 5,6,7-trimethylbaicalein derivatives. Chemical and Pharmaceutical Bulletin, 52(10), 1162–1165. https://doi.org/10.1248/cpb.52.1162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free